A Comparative Study of Palonosetron with Ondansetron for Prophylaxis of Postoperative Nausea and Vomiting (PONV) Following Laparoscopic Gynaecological Surgeries

[1] Halliday TA, Sundqvist J, Hultin M, Walldén J. Post-operative nausea and vomiting in bariatric surgery patients: an observational study. Acta Anaesthesiol Scand. 2017 May;61(5): 471–9. HallidayTA SundqvistJ HultinM WalldénJ Post-operative nausea and vomiting in bariatric surgery patients: an observational study Acta Anaesthesiol Scand 2017 May 61 5 471 9 10.1111/aas.1288428374473 Search in Google Scholar

[2] Apfel CC, Läärä E, Koivuranta M, Greim CA, Roewer N. A simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers. Anesthesiol. 1999 Sep;91(3):693–700. ApfelCC LääräE KoivurantaM GreimCA RoewerN A simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers Anesthesiol 1999 Sep 91 3 693 700 10.1097/00000542-199909000-0002210485781 Search in Google Scholar

[3] Apfel CC. Postoperative nausea and vomiting. Miller's Anesthesia. 2010:2729–55. ApfelCC Postoperative nausea and vomiting Miller's Anesthesia 2010 2729 55 10.1016/B978-0-443-06959-8.00086-8 Search in Google Scholar

[4] Chatterjee S, Rudra A, Sengupta S. Current concepts in the management of postoperative nausea and vomiting. Anesthesiol Res Pract. 2011;2011:748031. ChatterjeeS RudraA SenguptaS Current concepts in the management of postoperative nausea and vomiting Anesthesiol Res Pract 2011 2011 748031 10.1155/2011/748031321626922110499 Search in Google Scholar

[5] Gan TJ, Meyer T, Apfel CC, Chung F, Davis PJ, Eubanks S, et al. Consensus guidelines for managing postoperative nausea and vomiting. Anesth Analg. 2003 Jul;97(1):62–71, table of contents. GanTJ MeyerT ApfelCC ChungF DavisPJ EubanksS Consensus guidelines for managing postoperative nausea and vomiting Anesth Analg 2003 Jul 97 1 62 71 table of contents. 10.1213/01.ANE.0000068580.00245.9512818945 Search in Google Scholar

[6] Yang LPH, Scott LJ. Palonosetron: in the prevention of nausea and vomiting. Drugs. 2009 Nov 12;69(16):2257–78. YangLPH ScottLJ Palonosetron: in the prevention of nausea and vomiting Drugs 2009 Nov 12 69 16 2257 78 10.2165/11200980-000000000-0000019852528 Search in Google Scholar

[7] Kloth DD. New pharmacologic findings for the treatment of PONV and PDNV. Am J Health Syst Pharm. 2009 Jan 1;66(Suppl 1):S11–18. KlothDD New pharmacologic findings for the treatment of PONV and PDNV Am J Health Syst Pharm 2009 Jan 1 66 Suppl 1 S11 18 10.2146/ashp08046219106333 Search in Google Scholar

[8] Singh PM, Borle A, Gouda D, Makkar JK, Arora MK, Trikha A, et al. Efficacy of palonosetron in postoperative nausea and vomiting (PONV)-a meta-analysis. J Clin Anesth. 2016 Nov;34:459–82. SinghPM BorleA GoudaD MakkarJK AroraMK TrikhaA Efficacy of palonosetron in postoperative nausea and vomiting (PONV)-a meta-analysis J Clin Anesth 2016 Nov 34 459 82 10.1016/j.jclinane.2016.05.01827687434 Search in Google Scholar

[9] Kim SH, Hong JY, Kim WO, Kil HK, Karm MH, Hwang JH. Palonosetron has superior prophylactic antiemetic efficacy compared with ondansetron or ramosetron in high-risk patients undergoing laparoscopic surgery: A prospective, randomized, double-blinded study. Korean J Anesthesiol. 2013 Jun;64(6): 517–23. KimSH HongJY KimWO KilHK KarmMH HwangJH Palonosetron has superior prophylactic antiemetic efficacy compared with ondansetron or ramosetron in high-risk patients undergoing laparoscopic surgery: A prospective, randomized, double-blinded study Korean J Anesthesiol 2013 Jun 64 6 517 23 10.4097/kjae.2013.64.6.517369524923814652 Search in Google Scholar

[10] Lee WS, Lee KB, Lim S, Chang YG. Comparison of palonosetron, granisetron, and ramosetron for the prevention of postoperative nausea and vomiting after laparoscopic gynecologic surgery: a prospective randomized trial. BMC Anesthesiol. 2015 Sep 3;15:121. LeeWS LeeKB LimS ChangYG Comparison of palonosetron, granisetron, and ramosetron for the prevention of postoperative nausea and vomiting after laparoscopic gynecologic surgery: a prospective randomized trial BMC Anesthesiol 2015 Sep 3 15 121 10.1186/s12871-015-0102-0455883526335706 Search in Google Scholar

[11] Liu Q, Zhou C, Bao Z, Zhu Y. Effects of palonosetron and ondansetron on preventing nausea and vomiting after laparoscopic surgery. J Int Med Res. 2018 Jan;46(1):411–20. LiuQ ZhouC BaoZ ZhuY Effects of palonosetron and ondansetron on preventing nausea and vomiting after laparoscopic surgery J Int Med Res 2018 Jan 46 1 411 20 10.1177/0300060517715374601131928718727 Search in Google Scholar

[12] Kovac AL, Eberhart L, Kotarski J, Clerici G, Apfel C; Palonosetron 04–07 Study Group. A randomized, double-blind study to evaluate the efficacy and safety of three different doses of palonosetron versus placebo in preventing postoperative nausea and vomiting over a 72-hour period. Anesth Analg. 2008 Aug;107(2):439–44. KovacAL EberhartL KotarskiJ ClericiG ApfelC Palonosetron 04–07 Study Group A randomized, double-blind study to evaluate the efficacy and safety of three different doses of palonosetron versus placebo in preventing postoperative nausea and vomiting over a 72-hour period Anesth Analg 2008 Aug 107 2 439 44 10.1213/ane.0b013e31817abcd318633021 Search in Google Scholar

[13] Gan TJ, Belani KG, Bergese S, Chung F, Diemunsch P, Habib AS, et al. Fourth consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg. 2020;131(2):411–48. GanTJ BelaniKG BergeseS ChungF DiemunschP HabibAS Fourth consensus guidelines for the management of postoperative nausea and vomiting Anesth Analg 2020 131 2 411 48 10.1213/ANE.000000000000483332467512 Search in Google Scholar

[14] Dresner M, Dean S, Lumb A, Bellamy M. High-dose ondansetron regimen vs droperidol for morphine patient-controlled analgesia. Br J Anaesth. 1998 Sep;81(3):384–6. DresnerM DeanS LumbA BellamyM High-dose ondansetron regimen vs droperidol for morphine patient-controlled analgesia Br J Anaesth 1998 Sep 81 3 384 6 10.1093/bja/81.3.3849861125 Search in Google Scholar

[15] Watcha MF, White PF. Postoperative nausea and vomiting. Its etiology, treatment, and prevention. Anesthesiol. 1992 Jul;77(1):162–84. WatchaMF WhitePF Postoperative nausea and vomiting. Its etiology, treatment, and prevention Anesthesiol 1992 Jul 77 1 162 84 10.1097/00000542-199207000-000231609990 Search in Google Scholar

[16] Park SK, Cho EJ. A randomized, double-blind trial of palonosetron compared with ondansetron in preventing postoperative nausea and vomiting after gynaecological laparoscopic surgery. J Int Med Res. 2011;39(2):399–407. ParkSK ChoEJ A randomized, double-blind trial of palonosetron compared with ondansetron in preventing postoperative nausea and vomiting after gynaecological laparoscopic surgery J Int Med Res 2011 39 2 399 407 10.1177/14732300110390020721672343 Search in Google Scholar

[17] Gan TJ. Risk factors for postoperative nausea and vomiting. Anesth Analg. 2006 Jun;102(6):1884–98. GanTJ Risk factors for postoperative nausea and vomiting Anesth Analg 2006 Jun 102 6 1884 98 10.1213/01.ANE.0000219597.16143.4D16717343 Search in Google Scholar

[18] Janicki PK, Vealey R, Liu J, Escajeda J, Postula M, Welker K. Genome-wide association study using pooled DNA to identify candidate markers mediating susceptibility to postoperative nausea and vomiting. Anesthesiol. 2011 Jul;115(1):54–64. JanickiPK VealeyR LiuJ EscajedaJ PostulaM WelkerK Genome-wide association study using pooled DNA to identify candidate markers mediating susceptibility to postoperative nausea and vomiting Anesthesiol 2011 Jul 115 1 54 64 10.1097/ALN.0b013e31821810c721694509 Search in Google Scholar

[19] Rojas C, Stathis M, Thomas AG, Massuda EB, Massuda EB, Alt J, et al. Palonosetron exhibits unique molecular interactions with the 5-HT3 receptor. Anesth Analg. 2008 Aug;107(2):469–78. RojasC StathisM ThomasAG MassudaEB MassudaEB AltJ Palonosetron exhibits unique molecular interactions with the 5-HT3 receptor Anesth Analg 2008 Aug 107 2 469 78 10.1213/ane.0b013e318172fa7418633025 Search in Google Scholar

[20] Rojas C, Li Y, Zhang J, Stathis M, Alt J, Thomas AG, et al. The antiemetic 5-HT3 receptor antagonist palonosetron inhibits substance P-mediated responses in vitro and in vivo. J Pharmacol Exp Ther. 2010 Nov;335(2):362–8. RojasC LiY ZhangJ StathisM AltJ ThomasAG The antiemetic 5-HT3 receptor antagonist palonosetron inhibits substance P-mediated responses in vitro and in vivo J Pharmacol Exp Ther 2010 Nov 335 2 362 8 10.1124/jpet.110.166181320246920724484 Search in Google Scholar

[21] Nelson G, Altman AD, Nick A, Meyer LA, Ramirez PT, Achtari C, et al. Guidelines for pre- and intra-operative care in gynecologic/oncology surgery: Enhanced Recovery After Surgery (ERAS®) Society recommendations--Part I. Gynecol Oncol. 2016 Feb;140(2):313–22. NelsonG AltmanAD NickA MeyerLA RamirezPT AchtariC Guidelines for pre- and intra-operative care in gynecologic/oncology surgery: Enhanced Recovery After Surgery (ERAS®) Society recommendations--Part I Gynecol Oncol 2016 Feb 140 2 313 22 10.1016/j.ygyno.2015.11.01526603969 Search in Google Scholar

[22] Moon YE, Joo J, Kim JE, Lee Y. Anti-emetic effect of ondansetron and palonosetron in thyroidectomy: a prospective, randomized, double-blind study. Br J Anaesth. 2012 Mar;108(3):417–22. MoonYE JooJ KimJE LeeY Anti-emetic effect of ondansetron and palonosetron in thyroidectomy: a prospective, randomized, double-blind study Br J Anaesth 2012 Mar 108 3 417 22 10.1093/bja/aer42322277663 Search in Google Scholar

[23] Kazemi-Kjellberg F, Henzi I, Tramèr MR. Treatment of established postoperative nausea and vomiting: a quantitative systematic review. BMC Anesthesiol. 2001;1(1):2. Kazemi-KjellbergF HenziI TramèrMR Treatment of established postoperative nausea and vomiting: a quantitative systematic review BMC Anesthesiol 2001 1 1 2 10.1186/1471-2253-1-26065111734064 Search in Google Scholar

[24] Gan TJ. Mechanisms underlying postoperative nausea and vomiting and neurotransmitter receptor antagonist-based pharmacotherapy. CNS Drugs. 2007;21(10):813–33. GanTJ Mechanisms underlying postoperative nausea and vomiting and neurotransmitter receptor antagonist-based pharmacotherapy CNS Drugs 2007 21 10 813 33 10.2165/00023210-200721100-0000317850171 Search in Google Scholar

[25] Joslyn AF. Ondansetron, clinical development for postoperative nausea and vomiting: current studies and future directions. Anesth. 1994 Jan;49 Suppl:34–7. JoslynAF Ondansetron, clinical development for postoperative nausea and vomiting: current studies and future directions Anesth 1994 Jan 49 Suppl 34 7 10.1111/j.1365-2044.1994.tb03581.x7907459 Search in Google Scholar

[26] Navari RM. Palonosetron: A second-generation 5-hydroxytryptamine receptor antagonist. Future Oncol. 2006 Oct;2(5): 591–602. NavariRM Palonosetron: A second-generation 5-hydroxytryptamine receptor antagonist Future Oncol 2006 Oct 2 5 591 602 10.2217/14796694.2.5.59117026451 Search in Google Scholar

[27] Kim HJ, Lee HC, Jung YS, Lee J, Min JJ, Hong DM, et al. Effect of palonosetron on the QTc interval in patients undergoing sevoflurane anesthesia. Br J Anaesth. 2014 Mar;112(3):460–8. KimHJ LeeHC JungYS LeeJ MinJJ HongDM Effect of palonosetron on the QTc interval in patients undergoing sevoflurane anesthesia Br J Anaesth 2014 Mar 112 3 460 8 10.1093/bja/aet33524129597 Search in Google Scholar

[28] Gan TJ, Belani KG, Bergese S, et al. Fourth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting [published correction appears in Anesth Analg. 2020 Nov;131(5):e241]. Anesth Analg. 2020;131(2):411–448. GanTJ BelaniKG BergeseS Fourth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting [published correction appears in Anesth Analg. 2020 Nov;131(5):e241] Anesth Analg 2020 131 2 411 448 10.1213/ANE.000000000000483332467512 Search in Google Scholar